REMASTer: REcurrent Brain Metastases After SRS Trial
Condition(s):Brain Metastases; Radiation Necrosis; Recurrent Tumor; Recurrent MetastasesLast Updated:January 12, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Brain Metastases; Radiation Necrosis; Recurrent Tumor; Recurrent MetastasesLast Updated:January 12, 2024Recruiting
Condition(s):Cognitive ChangeLast Updated:January 16, 2024Completed
Condition(s):GlioblastomaLast Updated:August 24, 2021Terminated
Condition(s):EpilepsyLast Updated:August 14, 2019Terminated
Condition(s):Metastatic Brain Tumor; Primary Brain Tumor; Epileptic/Seizure Foci; Movement DisordersLast Updated:December 14, 2023Completed
Condition(s):Primary Brain TumorLast Updated:August 24, 2021Completed
Condition(s):Metastatic Brain Tumors; Progression; Radiation Necrosis; Quality of LifeLast Updated:August 24, 2021Completed
Condition(s):Brain Tumor; Brain Tumor, Recurrent; Brain Neoplasm; Brain Cancer; Glioblastoma Multiforme; Recurrent Glioblastoma MultiformeLast Updated:August 24, 2021Completed
Condition(s):Melanoma; Non-small Cell Lung Carcinoma (NSCLC); Renal Cell Carcinoma (RCC); Small-cell Lung Cancer; Head and Neck Squamous Cell Cancer; Classical Hodgkin Lymphoma; Primary Mediastinal Large B-Cell Lymphoma; Urothelial Carcinoma; Microsatellite Instability-High Cancer; Gastric Cancer; Esophageal Cancer; Cervical Cancer; Hepatocellular Carcinoma; Merkel Cell Carcinoma; Brain Metastases, AdultLast Updated:December 27, 2023Terminated
Condition(s):Malignant Glioma of Brain; GlioblastomaLast Updated:February 27, 2019Withdrawn
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.